Necrotizing Soft Tissue Infection
📧 Sign up to get email alerts when something new happens for Necrotizing Soft Tissue Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: MicroMatrix® Flex in Tunneling Wounds [NA]
Integra LifeSciences reports that a clinical trial evaluating MicroMatrix Flex for tunneling wounds has completed, involving conditions incl…
-
CLINICAL_TRIALS trial_result · 2024-07-24Clinical Trial Update: HAT for the Treatment of Sepsis Associated With NASTI [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating HAT for sepsis associated with necrotizing soft tissue infection was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2021-09-16Clinical Trial Update: Phase 3 Study of Reltecimod vs Placebo in Patients With Sepsis-associated Acute Kidney Injury [Phase 3]
Phase 3 trial of reltecimod versus placebo in sepsis-associated acute kidney injury was terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2018-04-23Clinical Trial Update: Systems Medicine to Study Necrotizing Soft Tissue Infections (NSTIs).
A Karolinska Institutet-led clinical trial applying systems medicine to necrotizing soft tissue infections has completed.
-
CLINICAL_TRIALS trial_result · 2016-09-30Clinical Trial Update: Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial [Phase 2]
A Phase 2 randomized controlled trial evaluating intravenous immunoglobulin for necrotizing soft-tissue infections has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: Biomarkers in Patients With Flesh-eating Bacterial Infections
Completed trial investigating biomarkers in patients with flesh-eating bacterial infections to understand disease biology and identify poten…